1. Identification of TOR signaling complexes;Abraham;Cell,2002
2. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile;Allander;Cancer Res.,2001
3. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt;Aoki;Proc. Natl. Acad. Sci. USA,2001
4. Atkin, M.B., Hidalgo, M., Stadler W., Logan, T., Dutcher, J.P., Hudes, G., Park, Y., Marshall, B., Boni, J., and Dukart, G. (2002). A randomized double-blind phase 2 study of intravenous CCI-779 administered weekly to patients with advanced renal cell carcinoma. Proc. Am. Soc. Clin. Oncol. 21:10a;36A.
5. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors;Bianco;Oncogene,2003